Connect with us

Business

Single-shot Johnson & Johnson vaccine ‘highly effective’ in preventing severe COVID-19 – SBS News

In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe disease was 85.9 per cent in the United States, 81.7 per cent in South Africa,…

Published

on

Article feature image

The single-shot Johnson & Johnson vaccine is highly effective in preventing severe COVID-19, including newer variants, according to documents released by the US Food and Drug Administration.
The news on Wednesday came as the US regulator was set to convene an independent panel Friday that will likely vote to authorise the vaccine, making it the third available in the country hit hardest by the coronavirus pandemic.
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending